CIK 0001824293 · <br>Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824369909
- Phone
- (619) 400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 8-K Event Delisting notice
- SC 13G/A Stake Amended Statement of Ownership
- S-4 Deal Registration Statement - Business Combination
- 4 Other disposition Director disposed of 28,517 shares (other)
- 8-K Event Material agreement · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
Page 15 of 21 · 403 filings